ACXP
Acurx Pharmaceuticals LLCNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$8.47M
P/E Ratio
—
EPS
$-3.79
Beta
-2.09
52W High
$21.00
52W Low
$1.33
50-Day MA
$2.93
200-Day MA
$3.68
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Acurx Pharmaceuticals LLC
Acurx Pharmaceuticals, LLC, a clinical-stage biopharmaceutical company, develops antibiotics to treat bacterial infections. The company is headquartered in Staten Island, New York.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | — |
| Operating Margin | 0.00% |
| Return on Equity | -160.80% |
| Return on Assets | -66.50% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $2.07 |
| Price-to-Book | 1.22 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | -3.54 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $4.30M |
| Float | $4.15M |
| % Insiders | 2.99% |
| % Institutions | 6.20% |
Analyst Ratings
Consensus ($17.00 target)
1
Strong Buy2
BuyMore HEALTHCARE Stocks
Data last updated: 5/25/2026